17:27 EST Mineralys Therapeutics (MLYS) files automatic mixed securities shelf
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MLYS:
- Mineralys Therapeutics reports Q3 EPS (52c), consensus (61c)
- Unusually active option classes on open November 10th
- Mineralys Therapeutics, Inc. (MLYS) Q3 Earnings Cheat Sheet
- Mineralys Therapeutics price target raised to $52 from $42 at H.C. Wainwright
- Mineralys Therapeutics completes enrollment in Phase 2 EXPLORE-OSA trial